I just wanted to say, Ms. Yeates, that the accord categorically said, and I am reading, “The strategy will include the following actions”, and that piece on assessing, developing, and costing options for catastrophic pharmaceutical coverage was number one on the list. I still haven't had an answer as to why it wasn't done. It was signed in the accord and a report was to be made in March 2006. Why have we not seen that?
On November 20th, 2012. See this statement in context.